176 related articles for article (PubMed ID: 23727081)
1. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.
Peterson D; Munger C; Crowley J; Corcoran C; Cruchaga C; Goate AM; Norton MC; Green RC; Munger RG; Breitner JC; Welsh-Bohmer KA; Lyketsos C; Tschanz J; Kauwe JS;
Alzheimers Dement; 2014 May; 10(3):366-71. PubMed ID: 23727081
[TBL] [Abstract][Full Text] [Related]
2. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.
Cruchaga C; Kauwe JS; Mayo K; Spiegel N; Bertelsen S; Nowotny P; Shah AR; Abraham R; Hollingworth P; Harold D; Owen MM; Williams J; Lovestone S; Peskind ER; Li G; Leverenz JB; Galasko D; ; Morris JC; Fagan AM; Holtzman DM; Goate AM
PLoS Genet; 2010 Sep; 6(9):e1001101. PubMed ID: 20862329
[TBL] [Abstract][Full Text] [Related]
3. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort.
Babić Leko M; Willumsen N; Nikolac Perković M; Klepac N; Borovečki F; Hof PR; Sonicki Z; Pivac N; de Silva R; Šimić G
Brain Behav; 2018 Nov; 8(11):e01128. PubMed ID: 30329219
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.
Del-Aguila JL; Fernández MV; Schindler S; Ibanez L; Deming Y; Ma S; Saef B; Black K; Budde J; Norton J; Chasse R; ; Harari O; Goate A; Xiong C; Morris JC; Cruchaga C
J Alzheimers Dis; 2018; 62(2):745-756. PubMed ID: 29480181
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
6. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
[TBL] [Abstract][Full Text] [Related]
7. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
Elias-Sonnenschein LS; Helisalmi S; Natunen T; Hall A; Paajanen T; Herukka SK; Laitinen M; Remes AM; Koivisto AM; Mattila KM; Lehtimäki T; Verhey FR; Visser PJ; Soininen H; Hiltunen M
PLoS One; 2013; 8(4):e59676. PubMed ID: 23573206
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study.
Yagi T; Kanekiyo M; Ito J; Ihara R; Suzuki K; Iwata A; Iwatsubo T; Aoshima K; ;
Alzheimers Dement (N Y); 2019; 5():364-373. PubMed ID: 31440579
[TBL] [Abstract][Full Text] [Related]
11. The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.
Zhou F; Wang D
Oncotarget; 2017 Jun; 8(26):43506-43520. PubMed ID: 28415654
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identified INSC gene associated with Trail Making Test Part A and Alzheimer's disease related cognitive phenotypes.
Wang K; Xu C; Smith A; Xiao D; Navia RO; Lu Y; Xie C; Piamjariyakul U;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110393. PubMed ID: 34224794
[TBL] [Abstract][Full Text] [Related]
14. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
[TBL] [Abstract][Full Text] [Related]
15. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
Hu X; Pickering E; Liu YC; Hall S; Fournier H; Katz E; Dechairo B; John S; Van Eerdewegh P; Soares H;
PLoS One; 2011 Feb; 6(2):e16616. PubMed ID: 21390209
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
[TBL] [Abstract][Full Text] [Related]
18. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.
Tarawneh R; Lee JM; Ladenson JH; Morris JC; Holtzman DM
Neurology; 2012 Mar; 78(10):709-19. PubMed ID: 22357717
[TBL] [Abstract][Full Text] [Related]
19. Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis.
Chandler J; Georgieva M; Desai U; Done N; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
J Prev Alzheimers Dis; 2024; 11(2):320-328. PubMed ID: 38374738
[TBL] [Abstract][Full Text] [Related]
20. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
